Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20973745rdf:typepubmed:Citationlld:pubmed
pubmed-article:20973745lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:20973745lifeskim:mentionsumls-concept:C0814812lld:lifeskim
pubmed-article:20973745lifeskim:mentionsumls-concept:C2348609lld:lifeskim
pubmed-article:20973745lifeskim:mentionsumls-concept:C0304522lld:lifeskim
pubmed-article:20973745lifeskim:mentionsumls-concept:C1875307lld:lifeskim
pubmed-article:20973745pubmed:dateCreated2010-12-14lld:pubmed
pubmed-article:20973745pubmed:abstractTextDiabetes is a global epidemic. The recommended goals for glycated hemoglobin (HbA1c), low-density lipoprotein cholesterol (LDL-C), and blood pressure are achieved only in a very small minority of patients. In this supplement to Metabolic Syndrome and Related Disorders, we review the data showing that the bile acid sequestrant colesevelam lowers both HbA1c and LDL-C in patients with diabetes. These data make colesevelam an attractive therapy to get more patients to achieve their LDL-C and HbA1c goals.lld:pubmed
pubmed-article:20973745pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:languageenglld:pubmed
pubmed-article:20973745pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:citationSubsetIMlld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20973745pubmed:statusMEDLINElld:pubmed
pubmed-article:20973745pubmed:monthDeclld:pubmed
pubmed-article:20973745pubmed:issn1557-8518lld:pubmed
pubmed-article:20973745pubmed:authorpubmed-author:JialalIIlld:pubmed
pubmed-article:20973745pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20973745pubmed:volume8 Suppl 1lld:pubmed
pubmed-article:20973745pubmed:ownerNLMlld:pubmed
pubmed-article:20973745pubmed:authorsCompleteYlld:pubmed
pubmed-article:20973745pubmed:paginationS1-2lld:pubmed
pubmed-article:20973745pubmed:dateRevised2011-7-20lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:meshHeadingpubmed-meshheading:20973745...lld:pubmed
pubmed-article:20973745pubmed:year2010lld:pubmed
pubmed-article:20973745pubmed:articleTitleBile acid sequestrants and diabetes: introduction and overview to the supplement.lld:pubmed
pubmed-article:20973745pubmed:affiliationLaboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, California, USA.lld:pubmed
pubmed-article:20973745pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
pubmed-article:20973745pubmed:publicationTypeIntroductory Journal Articlelld:pubmed